PDR001 + Panobinostat for Melanoma and NSCLC

Clinical trial NCT03982134 · WITHDRAWN

Trial details

NCT number: NCT03982134
Sponsor: Muhammad Furqan
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Non Small Cell Lung Cancer

Start date: 2019-09-01
Primary completion: 2021-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.